Skip to content

Trial Summary

Acronym:

JAVELIN Medley

ACTRN/NCT /ethics:

Scientific title:

A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line PlatinumContaining Chemotherapy

Sponsor / Cooperative group:

Trial & Patient Characteristics

Cancer TypeBladder
Trial TypeTreatment
PhasePhase II
Age Range-
Sex-
Tumour Stream Urothelial
Cancer StageLocally Recurrent or Locally Advanced; Metastatic or Widespread
Anticipated Start Date-
Anticipated End Date-

Participating Hospitals

HospitalIcon Cancer Centre Adelaide
Clinical Trial CoordinatorSue Yeend
Emailsue.yeend@icon.team
Phone08 8292 2204
Principal InvestigatorDr Francis Parnis
Recruitment StatusNot Yet Recruiting